Mednax Q1 GAAP loss $0.25/sh includes $57M debt charge; adj EPS $0.33

Pediatrix Medical Group, Inc.

2022-Q1 EPS reported -$0.25 revenue$482,229,000

Revenue $482M (+8% YoY); same-unit revenue +1.3%, volume +3.2%.
GAAP loss from continuing ops $20.9M ($0.25/sh) vs income $5.4M ($0.06/sh) prior year.
Adjusted EPS $0.33 vs $0.24 prior year; Adjusted EBITDA $50.7M vs $45.5M.
Issued $400M 5.375% notes due 2030; redeemed $1.0B 6.25% notes due 2027, causing $57M loss.
Cash from ops used $89.9M; total debt $799M at quarter end.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.